profile picture
Charles Mbata
I'm working on
14 days ago
We’ve built an AI-driven healthcare and biotech platforms for clinical research, objective , and programmable therapeutics. MyMonitor.ai transforms skin images into objective medical data, while MetalDrug advances deterministic therapeutic infrastructure for biotech and pharma.
I'm looking for
3 months ago
Seeking strategic partnerships with healthcare systems, pharma/biotech companies, CROs, academia, and innovation teams for healthcare AI validation, clinical trial modernization, dermatology infrastructure, programmable therapeutics, pilot programs, and enterprise deployment.
About
Founder & CEO of MyMonitor Corporation, building AI infrastructure for healthcare and clinical research, and Co-Founder of MetalDrug. MyMonitor's clinical execution platform spans clinical AI, intelligent eSource, AI Voice & Chat, medical imaging, patient screening, and workflow automation. We are also developing, a persistent-state architecture that achieved ~11.3× higher correct-task throughput than full-context replay in controlled testing environment. I bring ~15 years of Phase I–IV clinical research experience and seek collaborations in efficient AI inference, persistent memory, clinical AI, interoperability, imaging, and independent technical validation.
profile picture
Charles Mbata
Work experience
Partner
2025 - Present
Metal Drug
Partner
2024 - Present
Novartis
Expert Clinical Research Associate
2016 - 2024
Top industry applications
Medical diagnosticsPharmaceuticals and drug delivery
Expertise
Artificial IntelligenceBiochemistryBiomolecular ProcessesClinical PharmacologyComputational BiologyComputational Chemistry
Last updated Aug 2026
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.